Logo image of SGHC

SUPER GROUP SGHC LTD (SGHC) Stock Fundamental Analysis

NYSE:SGHC - New York Stock Exchange, Inc. - GG00BMG42V42 - Common Stock - Currency: USD

8.79  -0.28 (-3.09%)

Premarket: 8.7 -0.09 (-1.02%)

Fundamental Rating

5

SGHC gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 136 industry peers in the Hotels, Restaurants & Leisure industry. While SGHC has a great health rating, there are worries on its profitability. SGHC has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year SGHC was profitable.
SGHC had a positive operating cash flow in the past year.
In multiple years SGHC reported negative net income over the last 5 years.
Of the past 5 years SGHC 4 years had a positive operating cash flow.
SGHC Yearly Net Income VS EBIT VS OCF VS FCFSGHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 50M -50M 100M 150M 200M

1.2 Ratios

The Return On Assets of SGHC (-1.10%) is worse than 67.65% of its industry peers.
The Return On Equity of SGHC (-2.02%) is comparable to the rest of the industry.
With a decent Return On Invested Capital value of 10.40%, SGHC is doing good in the industry, outperforming 75.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SGHC is above the industry average of 14.24%.
The last Return On Invested Capital (10.40%) for SGHC is well below the 3 year average (17.17%), which needs to be investigated, but indicates that SGHC had better years and this may not be a problem.
Industry RankSector Rank
ROA -1.1%
ROE -2.02%
ROIC 10.4%
ROA(3y)15.84%
ROA(5y)13.87%
ROE(3y)26.29%
ROE(5y)N/A
ROIC(3y)17.17%
ROIC(5y)N/A
SGHC Yearly ROA, ROE, ROICSGHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 50 100 150 200

1.3 Margins

SGHC has a Operating Margin of 5.22%. This is in the lower half of the industry: SGHC underperforms 61.76% of its industry peers.
In the last couple of years the Operating Margin of SGHC has declined.
The Profit Margin and Gross Margin are not available for SGHC so they could not be analyzed.
Industry RankSector Rank
OM 5.22%
PM (TTM) N/A
GM N/A
OM growth 3Y-27.69%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SGHC Yearly Profit, Operating, Gross MarginsSGHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 5 -5 10 -10 15

More info and screens

7

2. Health

2.1 Basic Checks

SGHC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
SGHC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SGHC Yearly Shares OutstandingSGHC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 100M 200M 300M 400M
SGHC Yearly Total Debt VS Total AssetsSGHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 7.59 indicates that SGHC is not in any danger for bankruptcy at the moment.
SGHC has a Altman-Z score of 7.59. This is amongst the best in the industry. SGHC outperforms 94.12% of its industry peers.
The Debt to FCF ratio of SGHC is 0.37, which is an excellent value as it means it would take SGHC, only 0.37 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.37, SGHC belongs to the best of the industry, outperforming 92.65% of the companies in the same industry.
A Debt/Equity ratio of 0.05 indicates that SGHC is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.05, SGHC belongs to the top of the industry, outperforming 86.03% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.37
Altman-Z 7.59
ROIC/WACC1.17
WACC8.88%
SGHC Yearly LT Debt VS Equity VS FCFSGHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 1.26 indicates that SGHC should not have too much problems paying its short term obligations.
The Current ratio of SGHC (1.26) is better than 67.65% of its industry peers.
A Quick Ratio of 1.26 indicates that SGHC should not have too much problems paying its short term obligations.
The Quick ratio of SGHC (1.26) is better than 69.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.26
SGHC Yearly Current Assets VS Current LiabilitesSGHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 167.02% over the past year.
EPS 1Y (TTM)167.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%612.72%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%21.45%

3.2 Future

SGHC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.90% yearly.
Based on estimates for the next years, SGHC will show a quite strong growth in Revenue. The Revenue will grow by 10.52% on average per year.
EPS Next Y85.68%
EPS Next 2Y47.52%
EPS Next 3Y33.9%
EPS Next 5YN/A
Revenue Next Year13.58%
Revenue Next 2Y11.89%
Revenue Next 3Y10.52%
Revenue Next 5YN/A

3.3 Evolution

SGHC Yearly Revenue VS EstimatesSGHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
SGHC Yearly EPS VS EstimatesSGHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 19.98, which indicates a rather expensive current valuation of SGHC.
SGHC's Price/Earnings ratio is a bit cheaper when compared to the industry. SGHC is cheaper than 66.91% of the companies in the same industry.
When comparing the Price/Earnings ratio of SGHC to the average of the S&P500 Index (24.12), we can say SGHC is valued inline with the index average.
The Price/Forward Earnings ratio is 12.11, which indicates a correct valuation of SGHC.
80.88% of the companies in the same industry are more expensive than SGHC, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of SGHC to the average of the S&P500 Index (20.42), we can say SGHC is valued slightly cheaper.
Industry RankSector Rank
PE 19.98
Fwd PE 12.11
SGHC Price Earnings VS Forward Price EarningsSGHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

SGHC's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. SGHC is more expensive than 72.06% of the companies in the same industry.
SGHC's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 49.61
EV/EBITDA 23.68
SGHC Per share dataSGHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SGHC's earnings are expected to grow with 33.90% in the coming years.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y47.52%
EPS Next 3Y33.9%

More info and screens

2

5. Dividend

5.1 Amount

SGHC has a Yearly Dividend Yield of 1.76%. Purely for dividend investing, there may be better candidates out there.
SGHC's Dividend Yield is a higher than the industry average which is at 3.66.
SGHC's Dividend Yield is slightly below the S&P500 average, which is at 2.44.
Industry RankSector Rank
Dividend Yield 1.76%

5.2 History

SGHC does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
SGHC Yearly Dividends per shareSGHC Yearly Dividends per shareYearly Dividends per share 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

DPN/A
EPS Next 2Y47.52%
EPS Next 3Y33.9%
SGHC Yearly Income VS Free CF VS DividendSGHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

More info and screens

SUPER GROUP SGHC LTD

NYSE:SGHC (5/8/2025, 8:22:43 PM)

Premarket: 8.7 -0.09 (-1.02%)

8.79

-0.28 (-3.09%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-05 2025-08-05
Inst Owners8.76%
Inst Owner Change1.13%
Ins Owners5.11%
Ins Owner ChangeN/A
Market Cap4.44B
Analysts85.45
Price Target10.81 (22.98%)
Short Float %1.56%
Short Ratio2.68
Dividend
Industry RankSector Rank
Dividend Yield 1.76%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date03-10 2025-03-10 (0.04)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)112.42%
Min EPS beat(2)-1.96%
Max EPS beat(2)226.8%
EPS beat(4)2
Avg EPS beat(4)94.06%
Min EPS beat(4)-100%
Max EPS beat(4)251.4%
EPS beat(8)3
Avg EPS beat(8)45.68%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)9.93%
Min Revenue beat(2)9.42%
Max Revenue beat(2)10.44%
Revenue beat(4)4
Avg Revenue beat(4)6.94%
Min Revenue beat(4)1.57%
Max Revenue beat(4)10.44%
Revenue beat(8)6
Avg Revenue beat(8)3.82%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.64%
PT rev (3m)11.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)13.64%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.74%
Valuation
Industry RankSector Rank
PE 19.98
Fwd PE 12.11
P/S 2.74
P/FCF 49.61
P/OCF 29.61
P/B 7.56
P/tB 16.96
EV/EBITDA 23.68
EPS(TTM)0.44
EY5.01%
EPS(NY)0.73
Fwd EY8.26%
FCF(TTM)0.18
FCFY2.02%
OCF(TTM)0.3
OCFY3.38%
SpS3.21
BVpS1.16
TBVpS0.52
PEG (NY)0.23
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.1%
ROE -2.02%
ROCE 13.16%
ROIC 10.4%
ROICexc 18.07%
ROICexgc 149.85%
OM 5.22%
PM (TTM) N/A
GM N/A
FCFM 5.52%
ROA(3y)15.84%
ROA(5y)13.87%
ROE(3y)26.29%
ROE(5y)N/A
ROIC(3y)17.17%
ROIC(5y)N/A
ROICexc(3y)34.83%
ROICexc(5y)N/A
ROICexgc(3y)196.54%
ROICexgc(5y)N/A
ROCE(3y)21.74%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-27.69%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.49
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.37
Debt/EBITDA 0.15
Cap/Depr 65.16%
Cap/Sales 3.73%
Interest Coverage 40.67
Cash Conversion 84.51%
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 1.26
Altman-Z 7.59
F-Score4
WACC8.88%
ROIC/WACC1.17
Cap/Depr(3y)46.84%
Cap/Depr(5y)34.86%
Cap/Sales(3y)2.67%
Cap/Sales(5y)2.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)167.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%612.72%
EPS Next Y85.68%
EPS Next 2Y47.52%
EPS Next 3Y33.9%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%21.45%
Revenue Next Year13.58%
Revenue Next 2Y11.89%
Revenue Next 3Y10.52%
Revenue Next 5YN/A
EBIT growth 1Y-11.45%
EBIT growth 3Y-15.76%
EBIT growth 5YN/A
EBIT Next Year330.78%
EBIT Next 3Y78.28%
EBIT Next 5Y59.66%
FCF growth 1Y-43.03%
FCF growth 3Y-17.1%
FCF growth 5YN/A
OCF growth 1Y-20.35%
OCF growth 3Y-4.24%
OCF growth 5YN/A